Martin Olin
Chief Executive Officer at BERGENBIO ASA
Network origin in Martin Olin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 15 | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark
9
| Holding Company | Medical Specialties | 9 |
| Public Company | Medical Distributors | 6 | |
AirHelp Ltd.
 AirHelp Ltd. Packaged SoftwareTechnology Services AirHelp Ltd. develops mobile applications to claim compensation for delayed or cancelled flights. Its proprietary system tracks cancelled overbooked or delayed flights and automatically informs and helps customers about compensation rights. The firm provides assistance with the application for compensation and with possible proceedings. The company was founded by Greg Roodt, Nicolas Branas Michaelsen, Henrik Zillmer and Morten Lund in 2013 and is headquartered in Ely, The United Kingdom.
4
| Subsidiary | Packaged Software | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Olin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Chairman Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| Technical University of Denmark | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman President Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| University of Aarhus | College/University | Doctorate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chairman Corporate Officer/Principal Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| CURASIGHT A/S | Medical Specialties | Director/Board Member Chairman Chief Operating Officer | |
AirHelp Germany GmbH
 AirHelp Germany GmbH Internet Software/ServicesTechnology Services AirHelp Germany GmbH operates as a holding company, which assists travelers in legal matters that involve delayed and canceled flights, as well as denied boarding. It focuses on air passenger rights, flight delay compensation, flight cancellation compensation, missed connection compensation, overbooking compensation, denied boarding compensation, delayed baggage compensation, as well as airline strike compensation. The company was founded by Henrik Zillmer, Nicolas Michaelsen, and Greg Roodt in 2013 and is headquartered in Berlin, Germany. | Internet Software/Services | Chief Executive Officer Founder Founder | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| NNIT A/S | Information Technology Services | Director/Board Member Chairman Corporate Officer/Principal | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Helse Bergen HF Haukeland Universitetssjukehus
 Helse Bergen HF Haukeland Universitetssjukehus Medical/Nursing ServicesHealth Services Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The company was founded in 2001, and the CEO is Eivind Hansen. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Chairman | |
| GENMAB A/S | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Director/Board Member | |
| AEGIRBIO AB | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Director/Board Member | |
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Director of Finance/CFO | |
| London Business School | College/University | Masters Business Admin Graduate Degree | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Corporate Officer/Principal | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chairman | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Bactolife A/S
 Bactolife A/S BiotechnologyHealth Technology Bactolife A/S is a Danish industrial biotech company that specializes in developing biological solutions to strengthen the gut microbiome and combat antimicrobial resistance. Bactolife is based in Kongens Lyngby, Denmark and was founded in 2017 by Andreas Hougaard Laustsen, Per Falholt, Mads Laustsen, David Kauffmann, and Sandra Wingaard Thrane. The company has approximately 40 employees and uses its proprietary binding protein technology to select and produce binding proteins that act on toxins without targeting growth or killing bacteria directly. Bactolife is developing and marketing ingredients for various groups, including mothers and children, the elderly, immunodeficient individuals, travelers, deployed individuals, and animal health. The company has proof of concept for its technology, including its most advanced animal health product, ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea. Mads Laustsen has been the CEO since 2017. | Biotechnology | Founder Founder |
Statistics
International
| Denmark | 28 |
| United States | 9 |
| Sweden | 5 |
| Switzerland | 5 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 534 |
| Corporate Officer/Principal | 210 |
| Chairman | 172 |
| Independent Dir/Board Member | 134 |
| Chief Executive Officer | 110 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Göran Albert Ando | 44 |
| Jonathan Silverstein | 42 |
| Søren Lemonius | 39 |
| Martin Linde | 37 |
| Anders Hedegaard | 30 |
| Albert Cha | 30 |
| Jesper Brandgaard | 25 |
| Jens Jesper Ovesen | 25 |
| Bruce Carter | 25 |
| Anker Gunvald Lundemose | 25 |
| Sveinung Hole | 25 |
| Thomas Dyrberg | 24 |
| Steen Riisgaard | 24 |
| Ronald Eastman | 24 |
- Stock Market
- Insiders
- Martin Olin
- Company connections
